Beatrix Elsberger

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Breast Cancer Risk

Dna Damage Response

Placebo Controlled

Top Venues

Circulation. Cardiovascular imaging

Exploration of targeted anti-tumor therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Leanne Fleming, Solveiga Zibaite, Simon D Kyle, Kathleen Boyd, Vivien Green, James Mansell, Beatrix Elsberger, David Young
Insomnia prehabilitation in newly diagnosed breast cancer patients: Protocol for a pilot, multicentre, randomised controlled trial comparing nurse delivered sleep restriction therapy to sleep hygiene education (INVEST trial). PloS one 19 (8) (2024)
Leanne Fleming, Solveiga Zibaite, Simon D Kyle, Kathleen Boyd, Vivien Green, James Mansell, Beatrix Elsberger, David Young
Insomnia prehabilitation in newly diagnosed breast cancer patients: Protocol for a pilot, multicentre, randomised controlled trial comparing nurse delivered sleep restriction therapy to sleep hygiene education (INVEST trial). PloS one 19 (8) (2024)
David T Gamble, P James Ross, Hilal Khan, Andreas Unger, Lesley Cheyne, Amelia Rudd, Fiona R Saunders, Janaki Srivanasan, Sylvia Kamya, Graham W Horgan, Andrew Hannah, Santosh Baliga, Carlo Gabriele Tocchetti, Gordon Urquhart, Wolfgang A Linke, Yazan Masannat, Ahmed Mustafa, Mairi Fuller, Beatrix Elsberger, Ravi Sharma, Dana K Dawson
Impaired Cardiac and Skeletal Muscle Energetics Following Anthracycline Therapy for Breast Cancer. Circulation. Cardiovascular imaging 16 (10) (2023)
Dylan P McClurg, Gordan Urquhart, Trevor McGoldrick, Subarnarekha Chatterji, Zofia Miedzybrodzka, Valerie Speirs, Beatrix Elsberger
Analysis of the Clinical Advancements for BRCA -Related Malignancies Highlights the Lack of Treatment Evidence for BRCA -Positive Male Breast Cancer. Cancers 14 (13) (2022)
Eilidh Bruce, Stanislau Makaranka, Gordon Urquhart, Beatrix Elsberger
Does the gut microbiome environment influence response to systemic breast cancer treatment? Exploration of targeted anti-tumor therapy 2 (4) (2021)